These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 36209190)

  • 1. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options.
    Liu D; Huang SY; Sun JH; Zhang HC; Cai QL; Gao C; Li L; Cao J; Xu F; Zhou Y; Guan CX; Jin SW; Deng J; Fang XM; Jiang JX; Zeng L
    Mil Med Res; 2022 Oct; 9(1):56. PubMed ID: 36209190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression.
    McBride MA; Patil TK; Bohannon JK; Hernandez A; Sherwood ER; Patil NK
    Front Immunol; 2020; 11():624272. PubMed ID: 33613563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the Study of Immunosuppressive Mechanisms in Sepsis.
    Fu X; Liu Z; Wang Y
    J Inflamm Res; 2023; 16():3967-3981. PubMed ID: 37706064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis-Induced Immunosuppression.
    Torres LK; Pickkers P; van der Poll T
    Annu Rev Physiol; 2022 Feb; 84():157-181. PubMed ID: 34705481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the understanding and treatment of sepsis-induced immunosuppression.
    Venet F; Monneret G
    Nat Rev Nephrol; 2018 Feb; 14(2):121-137. PubMed ID: 29225343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in immunotherapeutic research of sepsis].
    Dong L; Lyu J; Ding L; Liu Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):184-187. PubMed ID: 28625271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression.
    Yao RQ; Ren C; Zheng LY; Xia ZF; Yao YM
    Front Immunol; 2022; 13():891024. PubMed ID: 35619710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research advances of myeloid-derived suppressor cells in sepsis-induced immunosuppression].
    Peng Z; Xu J; He Y; Sun D; Shang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):666-669. PubMed ID: 35924528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune disorders in sepsis and their treatment as a significant problem of modern intensive care.
    Łysenko L; Leśnik P; Nelke K; Gerber H
    Postepy Hig Med Dosw (Online); 2017 Aug; 71(1):703-712. PubMed ID: 28894043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sepsis: pathophysiology and clinical management.
    Gotts JE; Matthay MA
    BMJ; 2016 May; 353():i1585. PubMed ID: 27217054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
    Dellinger RP; Levy MM; Carlet JM; Bion J; Parker MM; Jaeschke R; Reinhart K; Angus DC; Brun-Buisson C; Beale R; Calandra T; Dhainaut JF; Gerlach H; Harvey M; Marini JJ; Marshall J; Ranieri M; Ramsay G; Sevransky J; Thompson BT; Townsend S; Vender JS; Zimmerman JL; Vincent JL; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Crit Care Med; 2008 Jan; 36(1):296-327. PubMed ID: 18158437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the host response in sepsis: current approaches and future evidence.
    Bode C; Weis S; Sauer A; Wendel-Garcia P; David S
    Crit Care; 2023 Dec; 27(1):478. PubMed ID: 38057824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SSC International Guideline 2016 - Management of Sepsis and Septic Shock].
    Rahmel T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 Feb; 53(2):142-148. PubMed ID: 29426052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy.
    Monneret G; Venet F
    Cytometry B Clin Cytom; 2016 Jul; 90(4):376-86. PubMed ID: 26130241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis: update in the management.
    Venkataraman R; Kellum JA
    Adv Chronic Kidney Dis; 2013 Jan; 20(1):6-13. PubMed ID: 23265591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential immunological mechanisms of sepsis.
    Zhang X; Zhang Y; Yuan S; Zhang J
    Front Immunol; 2024; 15():1434688. PubMed ID: 39040114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of sepsis and septic shock in infants and children.
    von Rosenstiel N; von Rosenstiel I; Adam D
    Paediatr Drugs; 2001; 3(1):9-27. PubMed ID: 11220406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac dysfunction in severe sepsis and septic shock.
    Zanotti-Cavazzoni SL; Hollenberg SM
    Curr Opin Crit Care; 2009 Oct; 15(5):392-7. PubMed ID: 19633546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.